Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 7:11 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 2,351 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Covid 19 Clear all

Conditions: COVID-19
Interventions: Not listed
Lead sponsor: Synairgen Research Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 29 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: COVID-19 Immunisation, Influenza Vaccine
Interventions: Patient letter and clinician communication; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 19 Years and older
Enrollment: 114,165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 2
States / cities: Rochester, Minnesota

Conditions: COVID-19
Interventions: Exercise; Behavioral
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 50 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: COVID-19 Respiratory Infection, Respiratory Syncytial Virus Infections, Rhinoviral Infections, Influenza Viral Infections
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 10,034 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Coronavirus Disease 2019
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2025
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland

Conditions: Colorectal Cancer Screening
Interventions: Semi-structured interviews-Patients, Semi-structured interviews-Health system; Other
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 82 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: COVID-19
Interventions: Bamlanivimab, Etesevimab, Placebo, VIR-7831, Bebtelovimab; Drug
Lead sponsor: Eli Lilly and Company; Industry
Eligibility: 12 Years and older
Enrollment: 1,755 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 127
States / cities: Birmingham, Alabama • Mesa, Arizona • Scottsdale, Arizona + 103 more

Conditions: COVID-19
Interventions: Crizanlizumab, 0.9% saline; Drug · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: SARS-CoV2 Infection
Interventions: General SARS-CoV-2 Communication, Rural-Targeted SARS-CoV-2 Communication; Behavioral
Lead sponsor: Michigan State University; Other
Eligibility: 18 Years and older
Enrollment: 264 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023
U.S. locations: 1
States / cities: Flint, Michigan

Conditions: COVID-19 Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome
Interventions: EV-Pure™ and WJ-Pure™, Placebo; Drug
Lead sponsor: Vitti Labs, LLC; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025
U.S. locations: 1
States / cities: Liberty, Missouri

Conditions: Corona Virus Infection, COVID-19, SARS-CoV 2, Nitric Oxide, Respiratory Disease, Pneumonia, Viral, Inhaled Nitric Oxide
Interventions: Nitric Oxide delivered via LungFit™ system; Device
Lead sponsor: Beyond Air Inc.; Industry
Eligibility: 22 Years to 65 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: COVID-19 Pneumonia
Interventions: Tociliuzumab; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 97 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 24
States / cities: Phoenix, Arizona • Fullerton, California • Los Angeles, California + 19 more

Conditions: SARS-CoV-2 Infection
Interventions: Moderna COVID-19 Vaccine; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 29 Years
Enrollment: 1,923 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021
U.S. locations: 51
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Tempe, Arizona + 45 more

Conditions: Coronavirus, Respiratory Infection, COVID
Interventions: Investigational IVD for coronaviruses; Device
Lead sponsor: BioFire Defense LLC; Industry
Eligibility: Not listed
Enrollment: 2,091 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 6
States / cities: Los Angeles, California • Washington D.C., District of Columbia • Tampa, Florida + 3 more

Conditions: Beliefs
Interventions: Corrective message framing and humor; Behavioral
Lead sponsor: Johns Hopkins Bloomberg School of Public Health; Other
Eligibility: 21 Years to 99 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Influenza,Human, COVID-19
Interventions: Investigational Influenza Vaccine, COVID-19 Vaccine, Investigational Influenza/COVID-19 Vaccine, Licensed Influenza Vaccine 1, Licensed Influenza Vaccine 2, Placebo; Biological · Combination Product · Other
Lead sponsor: BioNTech SE; Industry
Eligibility: 18 Years and older
Enrollment: 1,353 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 22
States / cities: Lake Forest, California • San Diego, California • Walnut Creek, California + 17 more

Conditions: COVID-19 Vaccines
Interventions: BNT162b2; Biological
Lead sponsor: BioNTech SE; Industry
Eligibility: 5 Years and older
Enrollment: 700 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 14
States / cities: Homestead, Florida • Miami Lakes, Florida • Atlanta, Georgia + 10 more

Conditions: COVID-19, SARS-CoV 2
Interventions: Seraph®-100 Microbind® Affinity Blood Filter; Device
Lead sponsor: Children's Hospital Medical Center, Cincinnati; Other
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Long-COVID
Interventions: Mitoquinone, Placebo; Dietary Supplement
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Covid19, ME/CFS, SARS COV2, Novel Coronavirus Infection, Neurocognitive Disorders, Cardiovascular Diseases
Interventions: Not listed
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 6,000 participants
Timeline: 2020 – 2025
U.S. locations: 8
States / cities: Los Angeles, California • San Francisco, California • New Haven, Connecticut + 5 more

Conditions: COVID-19
Interventions: Not listed
Lead sponsor: National Eye Institute (NEI); NIH
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Corona Virus Infection, Acute Respiratory Distress Syndrome, SARS-CoV Infection, Coronavirus, Coronavirus Infections
Interventions: Hydroxychloroquine, Placebo; Drug · Other
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 1,312 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 2
States / cities: Minneapolis, Minnesota

Conditions: Post SARS-CoV2 (COVID-19)
Interventions: Tele-exercise; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 50 Years to 85 Years
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Covid19
Interventions: Balance assessments; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Durham, North Carolina

Search by objective public record fields.

Pilot Test of COVID-19 Related Clinical Outcome Assessment Methodology and Qualitative Evidence of Content Validity

Evaluation of a Multilevel Intervention on Adult COVID-19 and Influenza Vaccination Rate

Exercise Interventions in Post-acute Sequelae of Covid-19

Infection Watch Study

COVID-19 Associated Lymphopenia Pathogenesis Study in Blood

Facilitators and Barriers to Cancer Screening: Stakeholder Perspectives on Implementation

A Study of Immune System Proteins in Participants With Mild to Moderate COVID-19 Illness

Crizanlizumab for Treating COVID-19 Vasculopathy

Rural Tailored COVID-19 Communication to Promote SARS-CoV-2 Antibody Testing in Saliva

Safety and Effectiveness of Placental Derived Exosomes and Umbilical Cord Mesenchymal Stem Cells in Moderate to Severe Acute Respiratory Distress Syndrome (ARDS) Associated With the Novel Corona Virus Infection (COVID-19)

Inhaled NO for the Treatment of COVID-19 Caused by SARS-CoV-2 (US Trial)

A Study to Investigate Intravenous Tocilizumab in Participants With Moderate to Severe COVID-19 Pneumonia

A Study of SARS CoV-2 Infection and Potential Transmission in Individuals Immunized With Moderna COVID-19 Vaccine

Prospective Clinical Evaluation of the BioFire Emerging Coronavirus Panel for the Detection of COVID-19 and Other Coronaviruses

Does Framing and Humor Improve the Effectiveness of Messages About COVID-19 Vaccine

A Study to Learn About Flu and COVID-19 Vaccine Responses in Healthy People

A Study of COVID-19 Vaccine(s) in Children and Adults

Registry of Seraph®-100 Microbind® Affinity Blood Filter for COVID-19 Under EUA

Long-term COVID and Rehabilitation

Innovative Support for Patients With SARS-COV2 Infections (COVID-19) Registry (INSPIRE)

Ocular Findings and Viral Persistence in Ocular Fluids in COVID-19 Survivors

Post-exposure Prophylaxis / Preemptive Therapy for SARS-Coronavirus-2

Home-Based Exercise Tele-Rehabilitation After COVID-19

Balance Function in Patients Post Corona Virus Disease 2019 (COVID-19)